My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Phathom Pharmaceuticals, Inc. - Common Stock (NQ:PHAT)

11.42 -0.56 (-4.67%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Phathom Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

IHS Holding Posts Upbeat Earnings, Joins Tencent Music Entertainment, Elbit Systems And Other Big Stocks Moving Higher On Tuesday ↗

March 18, 2025

Via Benzinga

Top Biotech Short Squeeze Stocks ↗

December 12, 2024

Investing in biotechnology stocks offers a unique opportunity for individuals looking to gain exposure to one of the most dynamic and innovative sectors of the market.

Via Talk Markets

Topics Stocks / Equities

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 03, 2024

Via Benzinga

These Are The Top 3 Most-Shorted Stocks In August 2024; Here’s Why ↗

August 21, 2024

Short-squeeze opportunities are tough to find. Combine market timing with fundamentals for these stocks.

Via Talk Markets

Preview: Phathom Pharmaceuticals's Earnings ↗

March 06, 2024

Via Benzinga

Recap: Phathom Pharmaceuticals Q3 Earnings ↗

November 09, 2023

Via Benzinga

Phathom Pharmaceuticals Resubmits FDA Application For Acid Blocker, Raises $131M Via Equity ↗

May 24, 2023

Via Benzinga

Analyst Expectations for Phathom Pharmaceuticals's Future ↗

May 11, 2023

Via Benzinga

Earnings Scheduled For March 6, 2025 ↗

March 06, 2025

Via Benzinga

Where Phathom Pharmaceuticals Stands With Analysts ↗

April 05, 2023

Via Benzinga

PHAT Stock Earnings: Phathom Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

PHAT stock results show that Phathom Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Ready for Quick Gains? 7 Top Short-Squeeze Stocks to Watch Now ↗

June 09, 2024

Each of the following seven heavily-shorted stocks may have what it takes to become one of the next big short squeeze stocks.

Via InvestorPlace

Ride the Gamma Wave: 3 Stocks on the Verge of a Short Squeeze ↗

June 07, 2024

Though short squeezes are never guaranteed, these three potential short squeeze stocks could provide generous returns if bought right.

Via InvestorPlace

The 3 Best Healthcare Stocks to Buy in May 2024 ↗

May 10, 2024

Healthcare firms can make large amounts of money, particularly in the U.S. Here are the three best healthcare stocks to buy now.

Via InvestorPlace

PHAT Stock Earnings: Phathom Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

PHAT stock results show that Phathom Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

PHAT Stock Earnings: Phathom Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023 ↗

March 07, 2024

PHAT stock results show that Phathom Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On Tuesday ↗

February 20, 2024

U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 16, 2024

Via Benzinga

Earnings Scheduled For March 7, 2024 ↗

March 07, 2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.

Via Benzinga

"Top Pick for 2024": Analyst Bullish On Phathom Pharmaceuticals On Voquezna Launch In Erosive GERD, Projecting $55.6M In Sales ↗

January 05, 2024

Needham analyst Joseph Stringer reiterated a Buy rating on Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT),

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 01, 2023

Via Benzinga

What's Going On With Phathom Pharmaceuticals Stock? ↗

October 30, 2023

Phathom Pharmaceuticals Inc (NASDAQ: PHAT) shares are trading higher Monday after the company announced FDA approval of its reformulated vo

Via Benzinga

Cramer Likes This Industrial Stock: A 'Well-Run' Company Doing 'A Lot Of Good Things' ↗

October 13, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended not buying ChargePoint Holdings, Inc.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023 ↗

August 09, 2023

Via Benzinga

3 Cheap Biotech Stocks That Smart Investors Will Snap Up Now ↗

August 07, 2023

One of the safest sectors on the market is biotech. Here are three cheap biotech stocks to buy that are good options for investors.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023 ↗

May 11, 2023

Via Benzinga

Insiders Buying Phathom Pharmaceuticals And 2 Other Stocks ↗

April 12, 2023

Although US stocks closed mixed on Tuesday, there were a few notable insider trades.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 04, 2023

Via Benzinga

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 30, 2023

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.